PZENA INVESTMENT MANAGEMENT LLC CVS CVS CORP Com

Ownership history in PZENA INVESTMENT MANAGEMENT LLC  ·  39 quarters on record

AI Ownership Summary

PZENA INVESTMENT MANAGEMENT LLC reported CVS CORP Com (CVS) in 39 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 4.18% in 2025 Q1. The latest visible filing shows CVS at 3.21% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CVS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was PZENA INVESTMENT MANAGEMENT LLC's position in CVS CORP Com, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CVS was reported at 3.21% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
4.18% in 2025 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How PZENA INVESTMENT MANAGEMENT LLC held CVS — position size vs. price
% of Fund (quarterly)    CVS price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED 13,773,053 -1,808,254 -11.6% 3.21% $989.2M 2026-04-24 $77.94
2025 Q4 REDUCED 15,581,307 -263,665 -1.7% 3.70% $1.24B 2026-02-06 $77.67
2025 Q3 REDUCED 5.4% +7.0% 15,844,972 -901,881 -5.4% 3.86% $1.19B 2025-11-07 $77.66
2025 Q2 REDUCED 5.3% +10.7% 16,746,853 -935,521 -5.3% 3.76% $1.16B 2025-07-25 $59.20
2025 Q1 REDUCED 9.8% +2.9% 17,682,374 -1,928,205 -9.8% 4.18% $1.20B 2025-05-02 $65.08
2024 Q4 ADDED 19,610,579 +6,475,271 +49.3% 3.00% $880.3M 2025-02-07 $51.57
2024 Q3 ADDED 13,135,308 +198,920 +1.5% 2.66% $825.9M 2024-11-08 $52.37
2024 Q2 ADDED 12,936,388 +7,382,931 +132.9% 2.69% $764.0M 2024-08-02 $55.32
2024 Q1 ADDED 5,553,457 +4,729,207 +573.8% 1.52% $442.9M 2024-05-03 $51.54
2023 Q4 REDUCED 33.3% +1.7% 824,250 -411,330 -33.3% 0.24% $65.1M 2024-02-09 $69.70
29 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About PZENA INVESTMENT MANAGEMENT LLC and CVS

These are the practical questions this page is built to answer before you even open the full history table.

How long has PZENA INVESTMENT MANAGEMENT LLC reported owning CVS?

PZENA INVESTMENT MANAGEMENT LLC reported CVS across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported CVS position in PZENA INVESTMENT MANAGEMENT LLC's portfolio?

The largest reported portfolio weight for CVS was 4.18% in 2025 Q1.

What is the latest reported CVS position on this page?

The most recent filing on this page is 2026 Q1, when PZENA INVESTMENT MANAGEMENT LLC reported 13,773,053 shares, equal to 3.21% of portfolio, with an estimated market value of $989.2M.

What does the chart on this CVS ownership page compare?

The chart compares PZENA INVESTMENT MANAGEMENT LLC's quarterly CVS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did PZENA INVESTMENT MANAGEMENT LLC time their CVS position?

Based on 13F filing dates vs. subsequent CVS price moves, PZENA INVESTMENT MANAGEMENT LLC correctly timed 20 out of 36 reported position changes (56%). The annualised alpha on CVS relative to SPY over the holding period was -10.8%.

← Back to PZENA INVESTMENT MANAGEMENT LLC Holdings